These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 24060976

  • 1. Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.
    Martinez-Becerra FJ, Chen X, Dickenson NE, Choudhari SP, Harrison K, Clements JD, Picking WD, Van De Verg LL, Walker RI, Picking WL.
    Infect Immun; 2013 Dec; 81(12):4470-7. PubMed ID: 24060976
    [Abstract] [Full Text] [Related]

  • 2. Broadly protective Shigella vaccine based on type III secretion apparatus proteins.
    Martinez-Becerra FJ, Kissmann JM, Diaz-McNair J, Choudhari SP, Quick AM, Mellado-Sanchez G, Clements JD, Pasetti MF, Picking WL.
    Infect Immun; 2012 Mar; 80(3):1222-31. PubMed ID: 22202122
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.
    Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF.
    J Immunol; 2014 Feb 15; 192(4):1630-40. PubMed ID: 24453241
    [Abstract] [Full Text] [Related]

  • 6. Mapping the functional B-cell epitopes of Shigella invasion plasmid antigen D (IpaD).
    Li S, Zhang W.
    Appl Environ Microbiol; 2024 Aug 21; 90(8):e0098824. PubMed ID: 39082807
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS, Kaur G, Sivaramakrishna U, Singh D, Bansal A.
    Vaccine; 2016 Oct 17; 34(44):5376-5383. PubMed ID: 27591952
    [Abstract] [Full Text] [Related]

  • 10. Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.
    Heine SJ, Franco-Mahecha OL, Chen X, Choudhari S, Blackwelder WC, van Roosmalen ML, Leenhouts K, Picking WL, Pasetti MF.
    Immunol Cell Biol; 2015 Aug 17; 93(7):641-52. PubMed ID: 25776843
    [Abstract] [Full Text] [Related]

  • 11. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV, Turbyfill KR.
    Vaccine; 2006 Mar 20; 24(13):2290-301. PubMed ID: 16364513
    [Abstract] [Full Text] [Related]

  • 12. Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.
    Lu T, Das S, Howlader DR, Jain A, Hu G, Dietz ZK, Zheng Q, Ratnakaram SSK, Whittier SK, Varisco DJ, Ernst RK, Picking WD, Picking WL.
    Front Immunol; 2023 Mar 20; 14():1194912. PubMed ID: 37744341
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei.
    Clarkson KA, Porter CK, Talaat KR, Frenck RW, Alaimo C, Martin P, Bourgeois AL, Kaminski RW.
    mSphere; 2021 Aug 25; 6(4):e0012221. PubMed ID: 34259559
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine.
    Venkatesan MM, Hartman AB, Newland JW, Ivanova VS, Hale TL, McDonough M, Butterton J.
    Infect Immun; 2002 Jun 25; 70(6):2950-8. PubMed ID: 12010984
    [Abstract] [Full Text] [Related]

  • 18. SipD and IpaD induce a cross-protection against Shigella and Salmonella infections.
    Jneid B, Rouaix A, Féraudet-Tarisse C, Simon S.
    PLoS Negl Trop Dis; 2020 May 25; 14(5):e0008326. PubMed ID: 32463817
    [Abstract] [Full Text] [Related]

  • 19. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.
    Sagi S, Konduru B, Parida M.
    Int Immunopharmacol; 2020 Aug 25; 85():106617. PubMed ID: 32464569
    [Abstract] [Full Text] [Related]

  • 20. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis.
    Mitra S, Chakrabarti MK, Koley H.
    Vaccine; 2013 Jun 28; 31(31):3163-73. PubMed ID: 23684822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.